Speaker: Sandra Axiak-Bechtel, DVM, DACVIM (Oncology)
Time: 8:30am - 4pm
Sandra Axiak-Bechtel, DVM, DACVIM (Oncology)
University of Missouri CVM
Sunday, April 19, 2015
8:30am - 4pm
Presentation Notes (Login Required)
Topic 1: Chemotherapy - mechanisms and toxicities
This lecture will cover the most common therapeutics used in veterinary medicine, goals with therapy, common and unique toxicities, and management of side effects.
Topic 2: Clinical trials - what we've learned and what's up and coming
We will cover the objectives and outcomes of recent clinical trials in canine/ feline cancer therapy in addition to reviewing ongoing clinical trials.
Topic 3: Lymphoma – update on diagnostics and treatment options
Using a case based approach, we will review lymphoma diagnosis in both dogs and cats, standard care, and new therapies.
Topic 4: Mast cell tumor – update on new treatments, classification schemes and effects on treatment decisions
Using a case based approach, we will review mast cell tumor diagnosis in dogs, the new staging scheme, prognostic indicators, standard care, and new therapies.
Topic 5: Mammary carcinoma – refresher on diagnosis, treatment, and prognosis
Using a case based approach, we will review mammary tumor diagnosis in both dogs and cats, prognostic indicators, standard care, and new therapies.
Topic 6: Cytology refresher
In an interactive case based discussion, we will review cytology slides, description, and diagnosis of common tumor types.
Dr. Sandra Axiak-Bechtel graduated from Michigan State University's College of Veterinary Medicine in 2004 followed by an internship at Mississippi State University and residency at Gulf Coast Veterinary Specialists. She achieved board certification in Medical Oncology in 2008 and practiced as an Associate Oncologist at Veterinary Specialists of North Texas in Dallas prior to joining the MU College of Veterinary Medicine as an Assistant Professor in Oncology in 2009. Her research focuses on improving the lives of companion animals with naturally occurring cancer and providing translational models for research in cancer causation, progression, and treatment. This focus provides advanced cancer therapy for companion animals and essential information for translation of novel treatments into people. Her scholarly activity in the area of Comparative and Translational Medicine is subdivided novel diagnostics and treatments in cancer therapy; immune system dysfunction and modulation in cancer; and nanomedicine in cancer therapy.